Wells Fargo & Company Raises Tenet Healthcare (NYSE:THC) Price Target to $115.00

Tenet Healthcare (NYSE:THC – Free Report) had its price objective lifted by Wells Fargo & Company from $105.00 to $115.00 in a report released on Thursday morning, Benzinga reports. They currently have an overweight rating on the stock. Other analysts also recently issued reports about the stock. Truist Financial upped their target price on shares […]

Related Keywords

United States ,Richardj Mark ,Richardw Fisher , ,Us Bancorp ,Barclays ,Xponance Inc ,Securities Exchange Commission ,Summerhaven Investment Management ,Yousif Capital Management ,Tenet Healthcare Company Profile ,Tenet Healthcare Corporation ,Northwestern Mutual Wealth Management Co ,Wells Fargo Company ,Tenet Healthcare ,Cantor Fitzgerald ,Free Report ,Wells Fargo ,Get Free Report ,Director Richard ,Exchange Commission ,Capital Management ,Haven Investment Management ,Northwestern Mutual Wealth Management ,Mutual Wealth Management ,Healthcare Corporation ,Hospital Operations ,Tenet Healthcare Daily ,Nyse Thc ,Thc ,Medical ,88033g40 ,Boost Price Target ,